SkinCure Oncology Celebrates National Radiologic Technology Week
SkinCure Oncology Chief Executive Officer
SkinCure Oncology employs some 400 radiation therapists who see patients as part of multidisciplinary treatment teams in 350 dermatology practices in 41 states.
During National Radiologic Technology Week the nation recognizes the critical role that radiation therapists, who are experts in medical imaging and radiation therapy, play in healthcare.
Brandt noted, "Our radiation therapists not only provide patients with the most advanced noninvasive treatment for nonmelanoma skin cancer, but they also engage with patients on a personal level throughout their treatment journeys for the ultimate patient experience. These dedicated professionals play a vital, advanced role in elevating the patient's voice in treatment decision-making, demystify the process and provide a deep connection and comprehensive care throughout. We are immensely grateful for all they do to change the face of skin cancer treatment."
About SkinCure Oncology
SkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure™ Experience, Image-Guided SRT is available from some 500 physicians nationwide, with nearly 100,000 patients having been treated. Learn more about the company at SkinCureOncology.com, and visit GentleCure.com for helpful consumer and patient information.
Media Contact:
Russell Public Communications
520-232-9840
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/skincure-oncology-celebrates-national-radiologic-technology-week-302292691.html
SOURCE SkinCure Oncology
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invictus Pharmacy and Mullan Pharmaceutical Inc. Announce Strategic Partnership to Expand Patient Access to FDA-Approved Ganirelix Acetate Injection Through Invictus Pharmacy
- Valstone Acquires Nascent, Expanding Its Industrial Transportation Technology Platform
- Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and Approximately 32% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Fo
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share